Yamamoto Hiroyasu, Schoonjans Kristina, Auwerx Johan
Institut de Génétique et de Biologie Moléculaire et Cellulaire, 1 Rue Laurent Fries, Boite Postale 10142, 67404 Illkirch, France.
Mol Endocrinol. 2007 Aug;21(8):1745-55. doi: 10.1210/me.2007-0079. Epub 2007 Apr 24.
Sirtuins or Sir2 (silent information regulator 2)-related enzymes have originally been defined as a family of nicotinamide adenine dinucleotide-dependent enzymes that deacetylate lysine residue on various proteins. Certain sirtuins have in addition an ADP-ribosyltransferase activity. The sirtuins are remarkably conserved throughout evolution from archaebacteria to eukaryotes. The mammalian sirtuins SIRT1-SIRT7 are implicated in a variety of cellular functions ranging from gene silencing, over the control of the cell cycle and apoptosis, to energy homeostasis. On a whole-body level, the wide range of cellular activities of the sirtuins suggests that they could constitute therapeutic targets to combat metabolic, neurodegenerative, and proliferative diseases. Here, we review some of the recent data related to the sirtuins and discuss their mode of action, their biological role in cellular and organismal models, and their possible association to age-related human diseases.
沉默调节蛋白或Sir2(沉默信息调节因子2)相关酶最初被定义为一类依赖烟酰胺腺嘌呤二核苷酸的酶,可使各种蛋白质上的赖氨酸残基去乙酰化。某些沉默调节蛋白还具有ADP核糖基转移酶活性。从古细菌到真核生物,沉默调节蛋白在整个进化过程中都非常保守。哺乳动物的沉默调节蛋白SIRT1 - SIRT7参与多种细胞功能,从基因沉默、细胞周期和细胞凋亡的控制到能量稳态。在全身水平上,沉默调节蛋白广泛的细胞活性表明它们可能构成对抗代谢性、神经退行性和增殖性疾病的治疗靶点。在此,我们综述了一些与沉默调节蛋白相关的最新数据,并讨论了它们的作用方式、在细胞和生物体模型中的生物学作用以及它们与人类年龄相关疾病的可能关联。